Time to Generate Is Not the ROI: Measure Time to Review
By Anant Agrawal, Head of AI, CIMCON Software. Based on my talk at ISPE on reviewing GenAI outputs The demo…
By Anant Agrawal, Head of AI, CIMCON Software. Based on my talk at ISPE on reviewing GenAI outputs The demo…
A widely cited MIT study published in July 2025, “The GenAI Divide: State of AI in Business 2025,” analyzed 300…
In February 2026, FDA finalized its Computer Software Assurance (CSA) guidance, reinforcing a risk-based, evidence-driven approach to computer system validation,…
In February 2026, FDA finalized its Computer Software Assurance (CSA) guidance, building on the 2022 draft version. For the first…
Artificial intelligence is moving faster than most corporate policy processes were designed to handle. That is especially true in financial…
Paper forms are still the primary data capture mechanism for a significant portion of GxP-relevant activities in pharmaceutical manufacturing, clinical…
Every pharmaceutical organization we speak with wants to use AI. Anomaly detection. Predictive quality. AI-accelerated validation. GenAI agents for deviation…
Data integrity programs in pharmaceutical organizations typically focus on what people do with data: how forms are completed, how records…
Spreadsheets are everywhere in pharmaceutical and life sciences organizations. Clinical trial data, raw material testing results, manufacturing logs, assay calculations,…
Spreadsheets, lab data, paper records, and AI: what the regulation requires, where organizations fail, and how to fix it. WHY…